Skip to main content
SpringerLink
Log in

Short-Term Mechanical Management of Cardiogenic Shock

  • Heart Failure
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Cardiogenic shock (CS), a state of cardiac dysfunction that results in systemic hypoperfusion and end-organ dysfunction, is associated with high in-hospital mortality. Various forms of mechanical circulatory support have been used to treat CS. First employed in the 1960s, the intra-aortic balloon pump (IABP) has been a mainstay in the treatment of acute CS. However, the IABP is unable to provide adequate support in many patients, and newer technologies, including extracorporeal membrane oxygenation and percutaneous ventricular assist devices, appear to be more effective in reversing CS. These devices are also useful for supporting patients during complex percutaneous coronary intervention. Perhaps most importantly, they can be used as a bridge to decision or definitive therapy in CS patients who are potential candidates for surgical ventricular assist devices or cardiac transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Abu-Omar Y, Tsui SS. Mechanical circulatory support for AMI and cardiogenic shock. J Card Surg. 2010;25:434–41.

    Article  PubMed  Google Scholar 

  2. Holmes Jr DR, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. J Am Coll Cardiol. 1995;26:668–74.

    Article  PubMed  Google Scholar 

  3. Aggarwal S, Slaughter MS. Acute myocardial infarction complicated by cardiogenic shock: role of mechanical circulatory support. Expert Rev Cardiovasc Ther. 2008;6:1223–35.

    Article  PubMed  Google Scholar 

  4. de Souza CF, de Souza Brito F, De Lima VC, De Camargo Carvalho AC. Percutaneous mechanical assistance for the failing heart. J Interv Cardiol. 2010;23:195–202.

    Article  PubMed  Google Scholar 

  5. Hollenberg SM, Kavinsky CJ, Parrillo JE. Cardiogenic shock. Ann Intern Med. 1999;131:47–59.

    PubMed  CAS  Google Scholar 

  6. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation. 1995;91:873–81.

    PubMed  CAS  Google Scholar 

  7. • Cheng JM, den Uil CA, Hoeks SE, et al.: Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009, 30:2102–8.

    Article  PubMed  Google Scholar 

  8. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–83.

    Article  PubMed  Google Scholar 

  9. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584–8.

    Article  PubMed  Google Scholar 

  10. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469.e461–8.

    Article  Google Scholar 

  11. Aziz TA, Singh G, Popjes E, et al. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant. 2010;29:66–71.

    Article  PubMed  Google Scholar 

  12. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–34.

    Article  PubMed  CAS  Google Scholar 

  13. Cyrus T, Mathews SJ, Lasala JM. Use of mechanical assist during high-risk PCI and STEMI with cardiogenic shock. Catheter Cardiovasc Interv. 2010;75 Suppl 1:S1–6.

    Article  PubMed  Google Scholar 

  14. Thomas JL, Al-Ameri H, Economides C, et al. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock. J Invasive Cardiol. 2010;22:360–4.

    PubMed  Google Scholar 

  15. Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2:91–6.

    Article  PubMed  Google Scholar 

  16. Gregoric ID, Jacob LP, La Francesca S, et al. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge). Tex Heart Inst J. 2008;35:125–9.

    PubMed  Google Scholar 

  17. • Ziemba EA, John R: Mechanical circulatory support for bridge to decision: which device and when to decide. J Card Surg. 2010, 25:425–33.

    Article  PubMed  Google Scholar 

  18. • Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P: The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011, 57:688–96.

    Article  PubMed  Google Scholar 

Download references

Disclosure

The authors report no potential conflicts of interest relevant to this article.

Author information

Authors and Affiliations

  1. Texas Heart Institute, PO Box 20345, MC 2-114A, Houston, TX, 77225–0345, USA

    Jessica L. Brown MD, Roberta C. Bogaev MD & Jack O’Connell MD

Authors
  1. Jessica L. Brown MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta C. Bogaev MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jack O’Connell MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberta C. Bogaev MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brown, J.L., Bogaev, R.C. & O’Connell, J. Short-Term Mechanical Management of Cardiogenic Shock. Curr Treat Options Cardio Med 13, 343–353 (2011). https://doi.org/10.1007/s11936-011-0133-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-011-0133-x

Keywords

Search

Navigation